Detalhe da pesquisa
1.
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.
Nature
; 615(7953): 697-704, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890230
2.
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.
Nat Commun
; 15(1): 1244, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336975
3.
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade.
Cancer Res Commun
; 2(10): 1214-1228, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588582
4.
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist.
Nat Commun
; 11(1): 660, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005809
5.
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
Clin Cancer Res
; 25(3): 1000-1011, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409823